Hyperammonaemia and Renal impairment

Summary:

Renal impairment is found among people with Hyperammonaemia, especially for people who are male, 60+ old.

The study analyzes which people have Renal impairment with Hyperammonaemia. It is created by eHealthMe based on reports of 18 people who have Hyperammonaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hyperammonaemia?

Hyperammonaemia is found to be associated with 402 drugs and 559 conditions by eHealthMe. Check the latest studies of Hyperammonaemia.

What is Renal impairment?

Renal impairment (severely reduced kidney function) is found to be associated with 2,209 drugs and 2,470 conditions by eHealthMe. Check the latest studies of Renal impairment.



On Jul, 13, 2026

18 people who have Hyperammonaemia and Renal Impairment are studied.

Would you have Renal impairment when you have Hyperammonaemia?

Gender of people who have Hyperammonaemia and experienced Renal Impairment *:

  • female: 38.89 %
  • male: 61.11 %

Age of people who have Hyperammonaemia and experienced Renal Impairment *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 6.67 %
  • 30-39: 0.0 %
  • 40-49: 13.33 %
  • 50-59: 33.33 %
  • 60+: 46.67 %

Common co-existing conditions for these people *:

  1. Ascites (accumulation of fluid in the abdominal cavity): 7 people, 38.89%
  2. Hepatitis B: 7 people, 38.89%
  3. Varices Oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach): 6 people, 33.33%
  4. Diabetes: 3 people, 16.67%
  5. Hepatocellular Carcinoma (liver cancer): 3 people, 16.67%
  6. Gastric Ulcer (stomach ulcer): 3 people, 16.67%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 11.11%
  8. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 1 person, 5.56%
  9. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 1 person, 5.56%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.56%

Common drugs taken by these people *:

  1. Baraclude: 6 people, 33.33%
  2. Lasix: 6 people, 33.33%
  3. Aldactone: 5 people, 27.78%
  4. Lenvima: 3 people, 16.67%
  5. Adefovir Dipivoxil: 2 people, 11.11%
  6. Amaryl: 2 people, 11.11%
  7. Omeprazole: 2 people, 11.11%
  8. Ammonul: 1 person, 5.56%
  9. Carbaglu: 1 person, 5.56%
  10. Cellcept: 1 person, 5.56%

Common symptoms for these people *:

  1. Hyperlactacidaemia (the acidosis and also reduces the capacity of the kidney): 6 people, 33.33%
  2. Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 6 people, 33.33%
  3. Blood Albumin Decreased: 5 people, 27.78%
  4. Hepatorenal Syndrome (renal failure in patients with advanced chronic liver disease): 5 people, 27.78%
  5. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 22.22%
  6. Diarrhea: 3 people, 16.67%
  7. Gastrointestinal Necrosis (destruction of gastrointestinal organ): 3 people, 16.67%
  8. Gastrointestinal Perforation (hole in the digestive tract): 3 people, 16.67%
  9. Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 3 people, 16.67%
  10. High Blood Pressure: 3 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Renal impairment?

- Check whether Renal impairment is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Renal impairment:

All the conditions that are associated with Renal impairment:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Renal impairment and Hyperammonaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: